Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine.
about
Panel 5: Microbiology and immunology panelPneumococcal Capsules and Their Types: Past, Present, and FutureThe effect of age on the response to the pneumococcal polysaccharide vaccine.Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.Serotype 6B from a pneumococcal polysaccharide vaccine induces cross-functional antibody responses in adults to serotypes 6A, 6C, and 6D.Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine.Panel 6: Vaccines.Identification of natural pneumococcal isolates expressing serotype 6D by genetic, biochemical and serological characterization.Multilocus sequence typing of Streptococcus pneumoniae by use of mass spectrometry.Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete.Novel pneumococcal serotypes 6C and 6D: anomaly or harbinger.Differential circulation of Streptococcus pneumoniae serotype 6C clones in two Israeli pediatric populations.Nasopharyngeal pneumococcal carriage of children attending day care centers in Korea: comparison between children immunized with 7-valent pneumococcal conjugate vaccine and non-immunized.Evolution of the capsular gene locus of Streptococcus pneumoniae serogroup 6.Clonal expansion within pneumococcal serotype 6C after use of seven-valent vaccine.Pneumococcal carriage in young children one year after introduction of the 13-valent conjugate vaccine in Italy.Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009.Streptococcus pneumoniae from Palestinian nasopharyngeal carriers: serotype distribution and antimicrobial resistance.Clonal expansion of the macrolide resistant ST386 within pneumococcal serotype 6C in FranceSynthesis, conjugation, and immunological evaluation of the serogroup 6 pneumococcal oligosaccharidesCarried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching.Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine.Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the NetherlandsVirulence of Streptococcus pneumoniae serotype 6C in experimental otitis mediaPediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.Bacterial Density, Serotype Distribution and Antibiotic Resistance of Pneumococcal Strains from the Nasopharynx of Peruvian Children Before and After Pneumococcal Conjugate Vaccine 7.Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A.Continued impact of pneumococcal conjugate vaccine on carriage in young children.Review on the immunogenicity and safety of PCV-13 in infants and toddlers.New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.Validation of factor 6d antiserum for serotyping Streptococcus pneumoniae serotype 6C.A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene.Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine.Identification of a simple chemical structure associated with protective human antibodies against multiple pneumococcal serogroupsProduction of a unique pneumococcal capsule serotype belonging to serogroup 6.Nasopharyngeal carriage of Streptococcus pneumoniae in healthy Turkish children after the addition of PCV7 to the national vaccine schedule.Molecular epidemiology of Streptococcus pneumoniae serogroup 6 isolates from Fijian children, including newly identified serotypes 6C and 6D.
P2860
Q26829692-3A6E5303-7DA4-40AF-B75F-F7EF8FF02B44Q27006887-C09C434F-EFBE-459D-8752-4F58E2F10E2EQ33539419-08B5A409-2628-4B0A-8274-066260AF2C5AQ33551026-6B8F343D-C297-49EA-B661-9CA96F70B240Q33595352-F1DEE9F9-53B3-4A1D-972A-EB849DDD01F8Q33614101-56C836AE-22E5-4DF2-9371-15996965CBA2Q33644678-5B9EDCCC-FCC8-4205-B68D-1F86AB2AE92DQ33931526-21802BD1-5D3E-43CB-A7FA-362C7C7414EBQ34006818-59F76FBC-8C80-4A6A-AF2A-AAEDF61A847DQ34235508-DE87244D-EE5D-4BB3-A54A-0BD3BF6EE6C4Q34294790-C91930BC-D40E-4A8C-8159-19A1E150DA5DQ34433118-63F3DCEA-6AFB-42AF-9B81-96AC83EC0B03Q34539923-27EA2399-9308-44E4-B5FE-F0D4C61F46A7Q34746789-7BAE0433-70AE-48B7-AF21-65E969D22FA9Q34749756-587830F1-65D5-47F1-8988-C43758B1011EQ35016927-481FD4E9-2311-401A-8259-84B8DC258F48Q35066883-606A68CC-DF45-4F42-9B03-3544E444841DQ35067669-2E975721-5800-411C-B128-AB2248F534EBQ35113108-B87B7DC7-1770-43E8-BD84-31891FCA42A8Q35155427-A0FF0C35-A07A-4B50-AA8C-7A1C3296359FQ35219958-048791EF-CDC9-4B9D-9388-04CB088F650CQ35785952-E219819E-0BEE-4036-93DE-A98E853D35E4Q35874108-319CA564-AB64-4BA7-AE20-DA3FE5AAE153Q35999835-30921DBB-60F0-49AF-B6E5-73EC54EC4D59Q36039569-07BA26A8-393D-4BBA-A915-5564EEA5E493Q36055346-8A1A26F5-5437-4A65-89AA-B9A3F808FE8DQ36156085-04DDA891-BB77-427C-8A75-23D9ED222523Q36763664-639F2FB5-B58D-40FF-937B-2D94A5C847E6Q37116534-DF79554C-B88E-415D-A788-655919041330Q37435825-94646E6B-F6EC-41A3-A1D8-130207B18F07Q37909417-74DB821C-E7B9-49AE-AC40-ACAC7B3E0D58Q38363735-C933B186-7FD1-4F6D-BC1C-F380A2B83459Q38366436-BC12F5BC-E33B-4986-AE35-0A903CF2955CQ39900955-F9DB01C1-2E4E-4293-89B4-887B71860114Q40880240-1726B40D-5143-4897-91ED-C90CA493F3A9Q41285540-5301184F-C735-45CD-B998-CF31175C6A94Q41995452-E4ED72A3-6583-472A-9E5F-4DAF01E69685Q42110468-49608A04-C115-4AB5-9D1D-B72560712787Q42247332-841949F6-2F01-4658-86E6-B861FD25D598Q42571322-15619866-58F3-4A7C-AC71-C8EF0CBD4EA3
P2860
Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increase in the prevalence of ...... neumococcal conjugate vaccine.
@en
Increase in the prevalence of ...... neumococcal conjugate vaccine.
@nl
type
label
Increase in the prevalence of ...... neumococcal conjugate vaccine.
@en
Increase in the prevalence of ...... neumococcal conjugate vaccine.
@nl
prefLabel
Increase in the prevalence of ...... neumococcal conjugate vaccine.
@en
Increase in the prevalence of ...... neumococcal conjugate vaccine.
@nl
P2093
P2860
P356
P1476
Increase in the prevalence of ...... neumococcal conjugate vaccine.
@en
P2093
Jisheng Lin
Jonathan A Finkelstein
Moon H Nahm
Stephen I Pelton
P2860
P304
P356
10.1086/596064
P407
P577
2009-02-01T00:00:00Z